Halliburton (HAL) PT Raised to $61 at Nomura Following Q3
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Nomura Securities analyst Matthew Johnston reiterated a Buy rating and lifted his price target on Halliburton (NYSE: HAL) to $61.00 (from $54.00) following Q3 results.
Johnston commented, "We continue to think HAL is the best way for investors to gain risk-adjusted exposure to an E&P spending recovery. The company has demonstrated the resilience and flexibility of its business model in North America, where 3Q results were driven by margins well in excess of expectations despite the fact that HAL only recently shifted from a successful market share grab campaign. HAL's leverage to the U.S. land market leaves it well positioned relative to large-cap peers."
FY16E EPS from ($0.19) to ($0.06); FY17E EPS from $1.33 to $1.18
Shares of Halliburton closed at $49.07 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- M&T Bank (MTB) PT Raised to $165 at FBR Capital Following 4Q Beat
- UPDATE: SunTrust Robinson Humphrey Downgrades Simon Property Group (SPG) to Hold
- Bassett Furniture (BSET) PT Raised to $28 at Stifel Following 4Q EPS Beat
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!